Efficacy of Methylene Blue in Sentinel Lymph Node Biopsy for Early Breast Cancer.

about

Methylene blue inhibits NLRP3, NLRC4, AIM2, and non-canonical inflammasome activation.Sentinel lymph node biopsy mapped with methylene blue dye alone in patients with breast cancer: A systematic review and meta-analysis

P2860

Q42004335-82CD8ABA-4E72-468E-AFB6-6C31C8498B12 Q57105831-B9044707-5797-4BAA-B086-AD2A8DF4EB2A

P2860

Efficacy of Methylene Blue in Sentinel Lymph Node Biopsy for Early Breast Cancer.

Item

http://www.wikidata.org/entity/Q41846391

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Efficacy of Methylene Blue in Sentinel Lymph Node Biopsy for Early Breast Cancer.

@en

type

Item

label

Efficacy of Methylene Blue in Sentinel Lymph Node Biopsy for Early Breast Cancer.

@en

prefLabel

Efficacy of Methylene Blue in Sentinel Lymph Node Biopsy for Early Breast Cancer.

@en

P1476

Efficacy of Methylene Blue in Sentinel Lymph Node Biopsy for Early Breast Cancer.

@en

P2093

Altan Özdemir

http://www.w3.org/2001/XMLSchema#string

Burhan Mayir

http://www.w3.org/2001/XMLSchema#string

Kenan Demirbakan

http://www.w3.org/2001/XMLSchema#string

Nezihi Oygür

http://www.w3.org/2001/XMLSchema#string

P2860

Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye

The role of selective sentinel lymph node dissection in breast cancer.

Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

Sentinel lymph node biopsy in primary breast cancer: window to management of the axilla.

Efficacy of methylene blue dye in localization of sentinel lymph node in breast cancer patients.

A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping.

Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization.

Outcomes of sentinel node biopsy for breast cancer in British Columbia, 1996 to 2001.

Safety and technical success of methylene blue dye for lymphatic mapping in breast cancer.

P304

88-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5152/TJBH.2014.1914

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265475651

http://www.w3.org/2001/XMLSchema#string

P698

28331650

http://www.w3.org/2001/XMLSchema#string

P932

5351475

http://www.w3.org/2001/XMLSchema#string

Efficacy of Methylene Blue in Sentinel Lymph Node Biopsy for Early Breast Cancer.

about

P2860

P2860

Efficacy of Methylene Blue in Sentinel Lymph Node Biopsy for Early Breast Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932